Fort Towson

LEO Pharma A/S is a multinational Danish pharmaceutical company, founded in 1908, with a presence in about 100 countries. Its headquarters are in Ballerup, near Copenhagen[2] The company is 100% integrated into a private foundation owned by the LEO Foundation.[3] LEO Pharma develops and markets products for dermatology, bone remodeling thrombosis and coagulation.[4] In 1945, it was the first producer of penicillin outside the US and UK.

History

Formation & the 20th Century

In 1908, pharmacists August Kongsted and Anton Antons bought the LEO Pharmacy in Copenhagen, Denmark. With the purchase, they established 'Københavns Løveapoteks kemiske Fabrik', today known as LEO Pharma. LEO Pharma celebrated its centennial in 2008.[5] Flags bearing the LEO logo were flying in every country where LEO products are available, more than a hundred flags in total. Today, LEO Pharma has an ever growing pipeline with over 4,800 specialists focusing on dermatology and thrombosis.

  • 1912 – The company launched its own Aspirin headache tablet
  • 1917 – The company exported Denmark's first drug, Digisolvin
  • 1940 – The company launched its own heparin product.
  • 1958 – Patent filed for bendrofluazide.[6]
  • 1962 – The company launched Fucidin to be used to treat staphylococcus infections.

21st Century & onwards

In 2015, the company announced it would acquire Astellas Pharmas dermatology business for $725 million.[7]

In 2018, the company acquired Bayer's dermatology unit for an undisclosed amount.[8]

In January 2023, the company started extensive layoffs[9] (of about 300 of its current employees, or ~5% of the workforce) as a part of major restructuring and reorganization in anticipation of a possibly planned IPO.[10] Because of slimming down of the company's R&D program, new early-stage drug candidates will have to be sourced externally.[11]

In August 2023, it was announced LEO Pharma had entered into a definitive agreement to acquire the Basking Ridge-headquartered biopharma company, Timber Pharmaceuticals.[12]

References

  1. ^ a b c "Archived copy" (PDF). Archived from the original (PDF) on 2015-11-17. Retrieved 2015-11-14.{{cite web}}: CS1 maint: archived copy as title (link)
  2. ^ Leo Pharma A/S published list of products Archived 2013-12-02 at the Wayback Machine
  3. ^ "About us - LEO Pharma". leo-pharma.com. Archived from the original on 2015-02-26. Retrieved 2013-11-06.
  4. ^ Highbeam news clipping service, UK
  5. ^ "LEO Pharma - BrandSearch" (PDF).
  6. ^ GB 863474, Lund, Frantz & Godtfredsen, Wagn Ole, "Benzothiadiazine derivatives and their preparation", published 1961-03-22 
  7. ^ "LEO Pharma Buys Astellas' Dermatology Business for $725M". GEN.
  8. ^ "Leo Pharma Acquires Bayer's Dermatology Unit". PharmaPhorum.
  9. ^ "Extensive layoffs at Leo Pharma – 300 jobs lost". MedWatch.
  10. ^ "Orphazyme CEO departs for Leo Pharma as both companies face major restructurings". EndpointsNews.
  11. ^ "Leo Pharma to source new drug candidates externally following layoffs". MedWatch.
  12. ^ "LEO Pharma to acquire Timber Pharmaceuticals in deal worth up to $36m". PMLive. 2023-08-23. Retrieved 2023-08-24.